76 related articles for article (PubMed ID: 515045)
21. The potentiating effect of an alpha-adrenergic blocking agent (E-643) on the action of bronchodilators.
Kitamura S; Ishihara Y; Yotsumoto H; Kosaka K
Arzneimittelforschung; 1980; 30(1):37-40. PubMed ID: 6102862
[TBL] [Abstract][Full Text] [Related]
22. [The mechanism of catecholamine potentiation of guinea pig seminal duct contractions].
Avakian OM; Pogasian AV
Farmakol Toksikol; 1972; 35(6):684-7. PubMed ID: 4651800
[No Abstract] [Full Text] [Related]
23. Potentiation by desmethylimipramine of ganglionic inhibition by catecholamines.
Kadzielawa K; Widy-Tyszkiewicz E
Arch Int Pharmacodyn Ther; 1969 Aug; 180(2):360-7. PubMed ID: 4310581
[No Abstract] [Full Text] [Related]
24. [Specific and nonspecific effects of beta adrenolytics].
Frey HH; Nielsen CK
Anaesthesist; 1967 May; 16(5):132-6. PubMed ID: 4385779
[No Abstract] [Full Text] [Related]
25. [Influence of gaseous hypocapnic alkalosis on broncho-motor effect of noradrenaline, adrenaline and isoprenaline].
Baïsset A; Cotonat J; Montastruc P; Tran MA
Therapie; 1970; 25(3):511-6. PubMed ID: 5431844
[No Abstract] [Full Text] [Related]
26. Potentiation by hydrocortisone of responses to catecholamines in vascular smooth muscle.
Besse JC; Bass AD
J Pharmacol Exp Ther; 1966 Nov; 154(2):224-38. PubMed ID: 5922985
[No Abstract] [Full Text] [Related]
27. Separation of the effects of alpha and beta adrenergic receptor stimulation on taenia coli.
Weisbrodt NW; Hug CC; Bass P
J Pharmacol Exp Ther; 1969 Dec; 170(2):272-80. PubMed ID: 5355980
[No Abstract] [Full Text] [Related]
28. Studies on the potentiation of the inotropic actions of certain catecholamines by U-0521 (3',4'-dihydroxy-alpha-methyl propiophenone).
Giles RE; Miller JW
J Pharmacol Exp Ther; 1967 Jul; 157(1):55-61. PubMed ID: 6029491
[No Abstract] [Full Text] [Related]
29. [Radioprotective action of catecholamines on a Chinese hamster fibroblast culture].
Chirkov IuIu; Malatsidze MA; Sobolev AS
Nauchnye Doki Vyss Shkoly Biol Nauki; 1985; (5):38-41. PubMed ID: 4027288
[TBL] [Abstract][Full Text] [Related]
30. [Relationship between the action of catecholamines and the pH of the environment].
Abramets II; Komissarov IV
Farmakol Toksikol; 1967; 30(5):580-4. PubMed ID: 5598920
[No Abstract] [Full Text] [Related]
31. [Cardiovascular reactivity of mini-pigs to catecholamines].
Fregnan GB
Boll Chim Farm; 1972 Oct; 111(10):598-609. PubMed ID: 4644473
[No Abstract] [Full Text] [Related]
32. [General aspect of adrenergic bronchoconstriction of type alpha].
Harichaux P; Moline J
J Physiol (Paris); 1967; 59(4 Suppl):426-7. PubMed ID: 5608773
[No Abstract] [Full Text] [Related]
33. [Effect of ascorbic acid and ACTH on the catecholamine and corticosteroid content in the organs of guinea pigs].
Lesnykh LD
Ukr Biokhim Zh; 1974; 46(4):499-506. PubMed ID: 4375876
[No Abstract] [Full Text] [Related]
34. Direct intrarenal action of catecholamines on renin secretion.
Vandongen R
Clin Exp Pharmacol Physiol; 1975; Suppl 2():103-7. PubMed ID: 1183075
[No Abstract] [Full Text] [Related]
35. Effect of oestradiol on catecholamine-stimulated lipolysis.
Lincová D; Miseková D; Elisová K; Wenke M
Physiol Bohemoslov; 1984; 33(4):342-52. PubMed ID: 6484025
[TBL] [Abstract][Full Text] [Related]
36. Catecholamine stimulation of brain hexokinase.
Harrison WH; Gray RM
Biochim Biophys Acta; 1971 May; 237(2):391-4. PubMed ID: 5571428
[No Abstract] [Full Text] [Related]
37. Effect of catecholamines and dibutyryl-cyclic-AMP on glucose turnover, plasma free fatty acids, and insulin in dogs treated with methylprednisolone.
Issekutz B; Borkow I
Can J Physiol Pharmacol; 1972 Oct; 50(10):999-1006. PubMed ID: 4344356
[No Abstract] [Full Text] [Related]
38. Studies on tetrahydroisoquinolines (THI). I. Bronchodilator activity and structure-activity relationship.
Iwasawa Y; Kiyomoto A
Jpn J Pharmacol; 1967 Jun; 17(2):143-52. PubMed ID: 4384069
[No Abstract] [Full Text] [Related]
39. Corticosteroid metabolism during the combined administration of ACTH and catecholamines.
DEMOOR P; HINNEKENS M; STEENO O; DECKX R; DELAERE K; MEULEP AS E
J Lab Clin Med; 1962 Jul; 60():138-49. PubMed ID: 13885356
[No Abstract] [Full Text] [Related]
40. Potentiation of catecholamine inhibition of ganglionic transmission by delta9-tetrahydrocannabinol.
Goldstein FJ; Vernot ET; Strahlendorf HK
Neuropharmacology; 1977 Jan; 16(1):71-2. PubMed ID: 189249
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
